Preparation of osteo-conductive device using nano-size apatite particles
Project/Area Number |
25463013
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Prosthodontics/ Dental materials science and
|
Research Institution | Iwate Medical University |
Principal Investigator |
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
Keywords | 生体材料 / ナノアパタイト / コラーゲン / 複合体 / 硬組織再生 / 医療デバイス / 架橋型ヒアルロン酸 / BMP / 注入型 / 硬組織形成 / 合成コラーゲン / ポリ乳酸共重合体 / コラーゲン複合体 |
Outline of Final Research Achievements |
We prepared collagen/nano-apatite composites by blending, and implanted them in rat cranial defects. It became evident that sponge composites were absorbed, but pressed composites had good osteo-conductive properties, leading to much new bone formation. It was suggested that pressed collagen/nano-apatite composites are new bone substitute materials. We also prepared crosslink-type hyaluronic acid/nano-apatite/BMP sols, and implanted them in mouse head, back and muscle. The materials (gel) induced bone formation at high rates. It was speculated that crosslink-type hyaluronic acid/nano-apatite/BMP composite might be used as safe injectable (sol-gel reaction type) osteo-cunductive medical device.
|
Report
(4 results)
Research Products
(13 results)
-
-
-
[Journal Article] Novel SCRG1/BST1 axis regulates self-renewal, migration, and osteogenic differentiation potential in mesenchymal stem cells.2014
Author(s)
Aomatsu E., Takahashi N., Sawada S, Okubo N, Hasegawa T, Taira M, Miura H, Ishisaki A, Chosa N.
-
Journal Title
Scientific Reports
Volume: 4
Pages: 3652-3652
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-